Millennium Beats Off-Label Suit, But Free Speech No Factor

Law360, New York (March 26, 2015, 6:23 PM EDT) -- A California federal judge on Thursday threw out a False Claims Act suit accusing Millennium Pharmaceuticals Inc. of illicit off-label promotion, but the ruling omitted any discussion of free-speech issues in the closely watched whistleblower case.

The decision from U.S. District Judge Morrison C. England Jr. tossed allegations from one-time sales representative Frank Solis under the FCA's public disclosure bar, finding the allegedly improper promotion of blood thinner Integrilin had been aired in five earlier cases brought in three other states.

"Examination of the five federal cases cited by [Millennium] shows markedly similar allegations with respect to the promotion of Integrilin,"...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!